Melphalan (Melpha) Inj 50 mg vial: Hospital supply issue
Luminarie, the incoming supplier of melphalan inj 50 mg vial (Melpha brand, Pharmacode 2647699), has notified of ongoing issues in sourcing stock.
21 June 2024 Update
The latest shipment of Megval (Pharmacode 2676842) should be available to order from Healthcare Logistics (HCL) from 21 June 2024. A small amount of stock arrived last week; this has all been dispatched already.
Affected product
In December 2023, Luminarie's Melpha brand gained principal supply status. There have been on-going supply issues affecting the supply of this product.
- Chemical: Melphalan
- Presentation: Inj 50 mg vial
- Brand: Melpha
- Pharmacode: 2647699
- Price: $48.25
- Measure / Qty: per 1
Alternatives
To cover this supply issue both the previously funded brand (Alkeran) and an alternative brand, Megval (Pharmacode 2676842) have been provided.
A small shipment of Megval arrived and was dispatched in the week beginning 17 June 2024. More stock is expected to be available from Healthcare Logistics (HCL) from 21 June 2024.
Expected resupply
Resupply of the registered brand (Melpha) has been delayed with no firm delivery date.
Who to contact
If you have questions about this issue, email enquiry@pharmac.govt.nz
Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.
Sign up to our email list for regular emails about supply issues and more(external link)